Success Story: NIW Approved Despite RFE! We Helped a Biomedical Science Researcher Secure Success

Posted by wegreened on November 3, 2026 in NIW,Biomedical Science

Client’s Testimonial:

“Overall, I had a very positive experience working with Chen. They were highly responsive, patient, and technical in their approach throughout the process. I particularly appreciated their strategy for responding to the RFE. They were thorough in preparing the response and addressing the concerns raised by USCIS.”

On September 28^th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Graduate Research Assistant in the Field of Biomedical Science (Approval Notice).

General Field: Biomedical Science

Position at the Time of Case Filing: Graduate Research Assistant

Country of Origin: Bangladesh

Approval Notice Date: September 28^th, 2026

Processing Time: 10 months, 7 days (Premium Processing Upgrade Requested)

Case Summary:

Infectious and autoimmune diseases continue to present complex challenges to national public health, pandemic preparedness, and healthcare infrastructure. Holding a Master of Science in biology, the client works as a researcher in biomedical science. His proposed endeavor focuses on identifying key host-pathogen protein interactions by utilizing advanced molecular biology and bioinformatic techniques to develop novel therapeutic targets and treatment strategies.

Overcoming the RFE: Strategic Positioning of Scientific Impact

The central objective in responding to the Request for Evidence (RFE) was to demonstrate to USCIS that the client's endeavor possessed national importance and that his past contributions established he was well-positioned to advance this work under Matter of Dhanasar. Rather than presenting raw publication and citation metrics as self-evidently sufficient, North America Immigration Law Group (Chen Immigration Law Associates) built a response analyzing how an adjudicator interprets scholarly influence within biomedical science:

Scholarly Output: Documented a body of work consisting of 6 peer-reviewed journal articles (1 first-authored) and 7 first-authored abstracts.
Bibliometric Standings: Evaluated his 38 citations using Essential Science Indicators (ESI) data, proving that one of his key publications ranked among the top 10% most-cited papers for its publication year. This demonstrated that independent researchers engaged with his findings at rates far exceeding discipline averages.
Independent Scientific Reliance: Highlighted concrete evidence showing that independent international research teams relied on his computational screening models, bioactive compound profiling, and metabolic pathway analyses to inform their own investigations into drug discovery and natural compound pharmacology.

Successful NIW Outcome

By framing the client's bioinformatic and molecular biology expertise around federal health objectives, top citation percentiles, and documented independent adoption, our firm successfully addressed the RFE queries. USCIS approved the I-140 NIW petition, validating the substantial merit and national importance of his ongoing contributions to biomedical science, host-pathogen research, and therapeutic target discovery in the United States.

--------------------------------------------

North America Immigration Law Group (Chen Immigration Law Associates) is a U.S. immigration law firm dedicated to representing corporations, research institutions, and individuals from all 50 U.S. states regarding I-140 immigration petitions. We specialize in employment-based immigration petition and have a proven record of high success rate for the categories of: EB2-NIW (National Interest Waiver), EB1-A (Alien of Extraordinary Ability), EB1-B (Outstanding Researcher/Professor) and O-1 (Alien of Extraordinary Ability).

Our Sixty-four Thousand I-140 Approvals Provide Unprecedented Insight into the USCIS Adjudication Trend

With nearly 70,000 EB-1A, EB-1B, EB-2 NIW and O-1 cases approved, we have first hand information on the manner in which the USCIS adjudicate I-140 cases. As the USCIS has constantly changed its adjudication standards for the EB-1A, EB-1B and EB-2 NIW categories, our firm's huge database of successful cases gives you unprecedented insight to USCIS adjudication trends. We carefully analyze the data for all of our cases and apply the results of our analyses toward giving our clients up-to-date advice and adapting our strategies such that we remain on par with the ever-shifting landscape of immigration law in the U.S. With us, you will always have access to important updates, strategies, and information so that you can make the most informed decisions about your case.

We Have Helped Tens of Thousands of Clients with Credentials and Backgrounds Similar to Yours

With our exceedingly large number of successful petitions, no matter what credentials you have, no matter your background and field of expertise, no matter your visa status or nationality, chances are we have helped hundreds or even thousands of clients just like you. Our clients are usually impressed with how well we understand their research and work. Our insight and understanding stems from the fact that we have handled many cases with elements similar to yours already, and this helps us devise the best strategies for each individual petition.

Vast Majority of Clients Came to Us Because of Referrals

For years, our firm has attracted new clients based solely on word of mouth, recommendations, and the positive collaboration experiences shared with them by their friends and family. We take pride in our reputation and work hard to ensure that we provide a green card application experience that our clients are happy to share with their friends and colleagues. That is how our cumulative total of approved cases grew from 600 in 2013 to nearly 70,000 in 2025.

Track Record of Success EB-1 and NIW Approvals

(2012.01 - 2025.12)

Category	Approval or Refund^®		Approval or Refiling^TM
	Approval or Refund^®
Category	Approved Sum	Success Rate	Approved Sum	Success Rate
NIW	42,047	99%	5,258	97%
EB1A	9,218	91%	4,534	86%
EB1B	1,488	98%	448	93%
Total	52,753	98%	10,240	92%